Featured Stories
Gary Kalbaugh to Moderate Panel at WSBA Crypto & Blockchain Summit
NEW YORK, Nov. 5 [Category: BizLaw/Legal] -- Cahill Gordon and Reindel, a law firm, posted the following news:
* * *
Gary Kalbaugh to Moderate Panel at WSBA Crypto & Blockchain Summit
*
Cahill partner Gary Kalbaugh will moderate the closing panel "Where It All Converges | Tokenization and the Reinvention of Capital Markets" at the WSBA Crypto & Blockchain Summit in New York City.
Gary and other leading experts speaking on the panel will discuss how tokenization is reinventing capital markets. Other sessions at the summit will cover topics including the institutional adoption of digital assets,
... Show Full Article
NEW YORK, Nov. 5 [Category: BizLaw/Legal] -- Cahill Gordon and Reindel, a law firm, posted the following news:
* * *
Gary Kalbaugh to Moderate Panel at WSBA Crypto & Blockchain Summit
*
Cahill partner Gary Kalbaugh will moderate the closing panel "Where It All Converges | Tokenization and the Reinvention of Capital Markets" at the WSBA Crypto & Blockchain Summit in New York City.
Gary and other leading experts speaking on the panel will discuss how tokenization is reinventing capital markets. Other sessions at the summit will cover topics including the institutional adoption of digital assets,the CLARITY Act, and the role of AI, quantum computing, and cybersecurity in finance. The summit will bring together leaders from law, accounting, data, security, and digital asset markets to discuss the future of institutional finance.
To learn more about this year's Crypto & Blockchain Summit and register, click here.
***
Original text here: https://www.cahill.com/news/events/2026-11-05-gary-kalbaugh-to-moderate-panel-at-wsba-crypto-blockchain-summit
UPDATE: SRP Increasing Releases from Bartlett and Stewart Mountain Dams
PHOENIX, Arizona, Nov. 1 [Category: BizEnergy] -- The Salt River Project, a public power utility and electricity provider, issued the following news:
* * *
UPDATE: SRP Increasing Releases from Bartlett and Stewart Mountain Dams
*
As storms continue to hit the SRP watershed on both the Salt and Verde rivers, SRP has increased releases to approximately 54,000 cubic feet per second (403,000 gallons per second) from Bartlett and Stewart Mountain dams on the Salt and Verde rivers to allow the water storage necessary for dam and public safety.
While water from earlier releases will be seen in the
... Show Full Article
PHOENIX, Arizona, Nov. 1 [Category: BizEnergy] -- The Salt River Project, a public power utility and electricity provider, issued the following news:
* * *
UPDATE: SRP Increasing Releases from Bartlett and Stewart Mountain Dams
*
As storms continue to hit the SRP watershed on both the Salt and Verde rivers, SRP has increased releases to approximately 54,000 cubic feet per second (403,000 gallons per second) from Bartlett and Stewart Mountain dams on the Salt and Verde rivers to allow the water storage necessary for dam and public safety.
While water from earlier releases will be seen in theValley by later tonight, this increased amount should be arriving in the Valley by 6 p.m. Monday, November 2. The releases are expected to continue over the next few days and may increase overnight depending on the amount of inflow into the reservoir system.
This is lining up to be a record-breaking fall for precipitation and inflows in the Salt and Verde River watersheds after three consecutive, low-runoff seasons. October and November inflows will likely be the highest in the Verde watershed since 1972, about eight times greater than average.
"SRP works with local government entities, emergency managers and other agencies to provide information and ensure public safety during these water releases. The public is encouraged to observe any signage on road closures," said Tim Skarupa, Senior Manager of Atmospheric Sciences and Hydrology.
Unlike the Colorado River system, which has been facing shortages due to the ongoing drought, the Salt and Verde reservoir systems are nearly in balance where annual demand is close to the annual supply. However, in wet years such as this year, runoff can exceed the available capacity of the reservoir system.
Cities and irrigation districts that take deliveries from the SRP system will be given the opportunity to take this additional water so it can be put to beneficial use. The water will also flow downstream in the normally dry Salt River and recharge the aquifer, which also benefits Valley cities and water providers.
The water will flow over Granite Reef Diversion Dam through the normally dry Salt River as it makes its way through the Valley.
Several roads located in the East and West Valley that were built in the normally dry Salt River riverbed will be closed. Updated road information can be found on the ADOT website at AZ511.com.
SRP is currently evaluating alternatives on increasing the storage capacity and mitigating future storage losses due to sedimentation for the Verde River reservoir system. A group of 23 partners, including tribal, agricultural and municipal organizations have committed to support the Bureau of Reclamation (Reclamation) feasibility study of options to modify Bartlett Dam to improve management of water resources provided by the Verde River.
***
Original text here: https://media.srpnet.com/update-srp-increasing-releases-from-bartlett-and-stewart-mountain-dams/
SRP Increasing Releases from Bartlett and Stewart Mountain Dams Following Record Fall Precipitation
PHOENIX, Arizona, Nov. 1 [Category: BizEnergy] -- The Salt River Project, a public power utility and electricity provider, issued the following news:
* * *
SRP Increasing Releases from Bartlett and Stewart Mountain Dams Following Record Fall Precipitation
*
Recent storms and near record runoff into SRP reservoirs this fall have prompted SRP to release approximately 20,000 cubic feet per second (150,000 gallons) from Bartlett and Stewart Mountain dams on the Salt and Verde rivers to allow the water storage necessary for dam and public safety.
This is lining up to be a record-breaking fall for
... Show Full Article
PHOENIX, Arizona, Nov. 1 [Category: BizEnergy] -- The Salt River Project, a public power utility and electricity provider, issued the following news:
* * *
SRP Increasing Releases from Bartlett and Stewart Mountain Dams Following Record Fall Precipitation
*
Recent storms and near record runoff into SRP reservoirs this fall have prompted SRP to release approximately 20,000 cubic feet per second (150,000 gallons) from Bartlett and Stewart Mountain dams on the Salt and Verde rivers to allow the water storage necessary for dam and public safety.
This is lining up to be a record-breaking fall forprecipitation and inflows in the Salt and Verde River watersheds after three consecutive, low-runoff seasons. October and November inflows will likely be the highest in the Verde watershed since 1972, about eight times greater than average.
"SRP constantly monitors the weather, watershed conditions and reservoir levels to maintain our reliable water supply for the Valley," said Tim Skarupa, Senior Manager of Atmospheric Sciences and Hydrology. "Water releases are one of the most important tools SRP uses to safely manage the reservoir system. These releases create capacity to capture runoff from fall storms, winter precipitation and spring snowmelt."
Unlike the Colorado River system, which has been facing shortages due to the ongoing drought, the Salt and Verde reservoir systems are nearly in balance where annual demand is close to the annual supply. However, in wet years such as this year, runoff can exceed the available capacity of the reservoir system.
Cities and irrigation districts that take deliveries from the SRP system will be given the opportunity to take this additional water so it can be put to beneficial use. The water will also flow downstream in the normally dry Salt River and recharge the aquifer, which also benefits Valley cities and water providers.
The water will flow over Granite Reef Diversion Dam through the normally dry Salt River as it makes its way through the Valley.
Several roads located in the East and West Valley that were built in the normally dry Salt River riverbed will be closed. Updated road information can be found at AZ 511. SRP works with local government entities, emergency managers and other agencies to provide information and ensure public safety at all levels during these water releases. The public is encouraged to observe any signage on road closures.
SRP is currently evaluating alternatives on increasing the storage capacity for the Verde River reservoir system. A group of 23 partners, including tribal, agricultural and municipal organizations have committed to support the Bureau of Reclamation (Reclamation) feasibility study of options to modify Bartlett Dam to improve management of water resources provided by the Verde River.
***
Original text here: https://media.srpnet.com/srp-increasing-releases-from-bartlett-and-stewart-mountain-dams-following-record-fall-precipitation/
Johnson & Johnson's Novel Shockwave Javelin Coronary IVL Catheter Delivers Positive Results in Pivotal FORWARD CAD IDE Study
NEW BRUNSWICK, New Jersey, Nov. 1 [Category: BizHealth & Beauty] -- Johnson and Johnson posted the following news release:
* * *
Johnson & Johnson's Novel Shockwave Javelin Coronary IVL Catheter Delivers Positive Results in Pivotal FORWARD CAD IDE Study
*
SAN DIEGO - November 1, 2026 - Today, Johnson & Johnson announced 30-day results from the FORWARD coronary artery disease (CAD) investigational device exemption (IDE) study evaluating the safety and effectiveness of the Shockwave Javelin Coronary Intravascular Lithotripsy (IVL) Catheter. The catheter, an investigational device in the U.S.,
... Show Full Article
NEW BRUNSWICK, New Jersey, Nov. 1 [Category: BizHealth & Beauty] -- Johnson and Johnson posted the following news release:
* * *
Johnson & Johnson's Novel Shockwave Javelin Coronary IVL Catheter Delivers Positive Results in Pivotal FORWARD CAD IDE Study
*
SAN DIEGO - November 1, 2026 - Today, Johnson & Johnson announced 30-day results from the FORWARD coronary artery disease (CAD) investigational device exemption (IDE) study evaluating the safety and effectiveness of the Shockwave Javelin Coronary Intravascular Lithotripsy (IVL) Catheter. The catheter, an investigational device in the U.S.,is designed for the treatment of calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting. The results were presented as featured clinical research at the 2026 Transcatheter Cardiovascular Therapeutics (TCT) congress in San Diego, California.
In the 158-patient pivotal cohort, event rates for the primary safety and effectiveness endpoints exceeded pre-specified performance goals. Key findings from the study include:
* 93.6% technical success rate (primary effectiveness endpoint, defined as successful Shockwave Javelin Coronary IVL-enabled lesion crossing without serious angiographic complications at final imaging).
* 93.4% freedom from major adverse cardiovascular events (primary safety endpoint, defined as a composite of cardiac death, myocardial infarction or target vessel revascularization) through 30 days.
Additionally, the study demonstrated low complication rates in a highly complex lesion population. Among treated lesions, 96% were moderately or severely calcified, with a mean diameter stenosis of 81% and chronic total occlusions present in 20% of lesions. Despite this, serious angiographic complications at final imaging were observed in only 1.3% of patients.
"Successfully treating heavily calcified lesions begins with being able to facilitate lesion crossing, an enduring challenge that can limit what physicians can achieve for patients," said Robert Yeh, M.D., MBA, global co-principal investigator of the study and Section Chief, Interventional Cardiology, Beth Israel Deaconess Medical Center.i "These findings represent an important step toward overcoming that barrier and creating a viable treatment path for patients whose disease may be beyond the reach of conventional balloon-based calcium modification approaches."
Coronary artery disease (CAD) is the leading cause of death globally, affecting an estimated 315 million people worldwide and approximately 1 in 20 adults over the age of 20 in the U.S.ii,iii,iv. In CAD, the buildup of cholesterol-rich deposits results in narrowing of the coronary arteries, reducing blood flow to the heart muscle. Among lesions that cannot be crossed with a balloon, more than 75% have moderate to severe calcification.v
"The FORWARD CAD IDE study shows that difficult to cross lesions may be treated successfully without compromising safety," said James Spratt, M.D., global co-principal investigator of the study and FRCP, St. George's University NHS Trust.[vi] "This study suggests that Javelin could help physicians manage patients with limited treatment options."
About the FORWARD CAD Study
The FORWARD CAD study is a prospective, multicenter, single-arm study conducted in 28 sites in the U.S. and U.K. The study enrolled 158 patients with severely stenosed, de novo calcified coronary artery lesions with moderate to severe calcification defined by angiography and either over 90% stenosis with lesion length <40mm or a chronic total occlusion (CTO) and a J_CTO score of 1. The co-global principal investigators of the study are Robert Yeh, M.D., MBA, Beth Israel Deaconess Medical Center and James Spratt, M.D., FRCP, St. George's University NHS Trust, and the U.S. principal investigator is Robert Riley, M.D., FACC, Overlake Medical Center & Clinics.
The investigational Shockwave Javelin Coronary IVL platform is designed with a single distal emitter that creates ultrasonic acoustic pressure waves, with a spherical energy field that extends beyond the tip of the catheter. This novel design enables lithotripsy delivery closer to highly stenosed calcified lesions than would be possible with balloon-based IVL platforms.
Cardiovascular Solutions from Johnson & Johnson
Across Johnson & Johnson, we are tackling the world's most complex and pervasive health challenges. Through a cardiovascular portfolio that provides healthcare professionals with advanced mapping and navigation, miniaturized tech, and precise ablation, we are addressing conditions with significant unmet needs such as heart failure, coronary and peripheral artery disease, stroke, and atrial fibrillation. We are the global leaders in heart recovery, circulatory restoration and the treatment of heart rhythm disorders, as well as an emerging leader in neurovascular care, committed to taking on two of the leading causes of death worldwide in heart failure and stroke. For more information on circulatory restoration, visit our website.
About Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow and profoundly impact health for humanity. Learn more about our MedTech sector's global scale and deep expertise in cardiovascular, orthopaedics, surgery and vision solutions at https://www.jnjmedtech.com/en-US/. Follow us at @JNJMedTech and on LinkedIn. Shockwave Medical, Inc. is a Johnson & Johnson company.
Cautions Concerning Forward-Looking Statements
This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. Risks and uncertainties include, but are not limited to: competition, including technological advances, new products and patents attained by competitors; uncertainty of commercial success for new products; the ability of the company to successfully execute strategic plans; impact of business combinations and divestitures; challenges to patents; changes in behavior and spending patterns or financial distress of purchasers of health care products and services; and global health care reforms and trends toward health care cost containment. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson's most recent Annual Report on Form 10-K, including in the sections captioned "Cautionary Note Regarding Forward-Looking Statements" and "Item 1A. Risk Factors," and in Johnson & Johnson's subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, www.jnj.com, www.investor.jnj.com or on request from Johnson & Johnson. Johnson & Johnson does not undertake to update any forward-looking statement as a result of new information or future events or developments.
Source: Johnson & Johnson
Footnotes
i Dr. Robert Yeh is a paid consultant for Shockwave Medical. He has not been compensated in connection with this press release.
ii Centers for Disease Control and Prevention. About Coronary Artery Disease (CAD). https://www.cdc.gov/heart-disease/about/coronary-artery-disease.html. Last Accessed: March 24, 2025.
iii Centers for Disease Control and Prevention. Heart Disease Facts. https://www.cdc.gov/heart-disease/data-research/facts-stats/index.html. Last Accessed: March 24, 2025.
iv https://www.jacc.org/doi/10.1016/S0735-1097%2824%2904310-9
v Salem et al. Catheter Cardiovasc Interv. 2022 Jun;99(7):2028-2037.
vi Dr. James Spratt is a paid consultant for Shockwave Medical. He has not been compensated in connection with this press release.
***
Original text here: https://www.jnj.com/media-center/press-releases/johnson-johnsons-novel-shockwave-javelin-coronary-ivl-catheter-delivers-positive-results-in-pivotal-forward-cad-ide-study (TNSmrp)
Highmark Announces Affordable Care Act Products in Southeastern Pennsylvania for 2027
PITTSBURGH, Pennsylvania, Nov. 1 [Category: BizInsurance] -- Highmark, a health insurance company, issued the following news release:
* * *
Highmark Announces Affordable Care Act Products in Southeastern Pennsylvania for 2027
*
PHILADELPHIA (November 1, 2026) -- Highmark announced its Affordable Care Act (ACA) health insurance products in Southeastern Pennsylvania for 2026, offering individuals and families high-quality and convenient coverage options to fit their lives and health goals.
"For Americans who don't receive insurance through work or another government program, the ACA marketplace
... Show Full Article
PITTSBURGH, Pennsylvania, Nov. 1 [Category: BizInsurance] -- Highmark, a health insurance company, issued the following news release:
* * *
Highmark Announces Affordable Care Act Products in Southeastern Pennsylvania for 2027
*
PHILADELPHIA (November 1, 2026) -- Highmark announced its Affordable Care Act (ACA) health insurance products in Southeastern Pennsylvania for 2026, offering individuals and families high-quality and convenient coverage options to fit their lives and health goals.
"For Americans who don't receive insurance through work or another government program, the ACA marketplaceprotects and connects them to high-quality care," says Mike Pelino, senior director of market strategy and analytics for Highmark. "We encourage consumers to contact our enrollment experts and find the plan that's right for them."
Roughly 75% of Highmark's ACA Marketplace members in Pennsylvania qualify for tax credits that make their coverage more affordable, and 4 out of 5 can find a plan for $21 or less per month after tax credits in 2027.
"While some national, for-profit insurers enter and exit the ACA marketplace, Highmark has been trusted partner for ACA consumers since the program started more than a decade ago," says Ellen Galardy, president of Federal Business at Highmark. "ACA plans cover all ten essential health benefits, including doctor visits and maternity care, and provide access to important preventive care at no cost to the member. All bronze and catastrophic Individual ACA plans are eligible to be paired with a Health Savings Account, allowing members to use tax-advantaged funds to pay for their care. And, in 2027, we are offering a new bronze plan with a $0 deductible, including prescription medications. It's a great option for cost-conscious consumers looking for first-dollar coverage."
2027 Individual and Family plans
Highmark will offer my Blue Access PPO plans in the five Southeastern Pennsylvania counties for 2027. These plans provide individuals and families with access to Highmark's broadest network of doctors and hospitals, including Jefferson Health, Penn Medicine, and Children's Hospital of Philadelphia.
Plus, no plans require referrals to see a specialist and include in-network coverage for services received from 97 percent of hospitals and over 2 million providers nationwide through the BlueCard(r) program, including facilities in Maryland, New York, and New Jersey.
While the open enrollment period runs through January 15, consumers must enroll by December 15 for coverage that starts on January 1. For more information on Highmark's 2027 ACA health insurance products, visit Highmark.com or call 888-510-1084.
About Highmark Blue Shield
Highmark Inc., doing business as Highmark Blue Shield - the only statewide Blues plan in Pennsylvania and with its affiliated Highmark Blue Plans collectively comprises the 3rd Iargest Blue Plan - protects Pennsylvania individuals and families with a range of high-quality, affordable and reliable health insurance solutions. As the only Blue Shield licensee in Pennsylvania, Highmark Blue Shield has a long and successful history of delivering remarkable experiences in Southeastern Pennsylvania through the Federal Employee Program. Highmark Blue Shield earned a Brand Excellence Award from the national Blue Cross Blue Shield Association, in recognition of its efforts in building brand strength and providing superior customer service, solid financial performance and enrollment growth. Highmark Blue Shield is an independent licensee of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield companies. For more information, visit www.highmark.com.
Denee Crumrine
Highmark Health
302-421-2448
Denee.crumrine@highmarkhealth.org
***
Original text here: https://www.highmark.com/newsroom/press-releases/highmark-announces-affordable-care-act-products-in-southeastern-pennsylvania-for-2027
Highmark Announces 2027 Affordable Care Act Products in New York
PITTSBURGH, Pennsylvania, Nov. 1 [Category: BizInsurance] -- Highmark, a health insurance company, issued the following news release:
* * *
Highmark Announces 2027 Affordable Care Act Products in New York
*
Buffalo, N.Y. (November 1, 2026) -- Highmark Blue Cross Blue Shield announced its Individual Market Affordable Care Act (ACA) health insurance products for 2027 in Western and Northeastern New York, offering individuals and families high-quality and convenient coverage options to fit their lives and health goals.
"For Americans who don't receive insurance through work or another government
... Show Full Article
PITTSBURGH, Pennsylvania, Nov. 1 [Category: BizInsurance] -- Highmark, a health insurance company, issued the following news release:
* * *
Highmark Announces 2027 Affordable Care Act Products in New York
*
Buffalo, N.Y. (November 1, 2026) -- Highmark Blue Cross Blue Shield announced its Individual Market Affordable Care Act (ACA) health insurance products for 2027 in Western and Northeastern New York, offering individuals and families high-quality and convenient coverage options to fit their lives and health goals.
"For Americans who don't receive insurance through work or another governmentprogram, the ACA marketplace protects and connects them to high-quality care," says Mike Pelino, senior director of market strategy and analytics for Highmark. "We encourage consumers to contact our enrollment experts and find the plan that's right for them."
"While some national, for-profit insurers enter and exit the ACA marketplace, Highmark has been trusted partner for ACA consumers since the program started more than a decade ago," says Ellen Galardy, president of Federal Business at Highmark. "ACA plans cover all ten essential health benefits, including doctor visits and maternity care, and provide access to important preventive care at no cost to the member. All bronze and catastrophic Individual ACA plans are eligible to be paired with a Health Savings Account, allowing members to use tax-advantaged funds to pay for their care. And, in 2027, we are offering a new bronze plan with a $0 deductible, including prescription medications. It's a great option for cost-conscious consumers looking for first-dollar coverage."
2027 Individual and Family plans
Highmark will offer my Blue Access EX plans in all eight counties of Western New York and all 13 counties of Northeastern New York for 2027. These plans provide individuals and families with access to Highmark's broadest network of doctors and hospitals.
Plus, no plans require referrals to see a specialist and include in-network coverage for services received from 97 percent of hospitals and over 2 million providers nationwide through the BlueCard(r) program, including facilities in Pennsylvania, Massachusetts, and New York City.
While the open enrollment period runs through January 31, consumers must enroll by December 15 for coverage that starts on January 1. For more information on Highmark's 2027 ACA health insurance products, visit Highmark.com or call 855-344-3425.
About Highmark Blue Cross Blue Shield of Western New York
Highmark Western and Northeastern New York Inc., doing business as Highmark Blue Cross Blue Shield, is the region's largest and longest-standing health plan, with roots in Western New York dating back to 1936. Today, it is an affiliate of Highmark Inc. and other Highmark health plans, which collectively comprise the third largest overall Blue Cross Blue Shield-affiliated organization in the country with nearly 8 million members in Pennsylvania, Delaware, New York, West Virginia, Missouri and Kansas. The company insures over 500k members and employs more than 1,400 team members across New York State. It is one of the region's strongest corporate citizens, investing over $8 million into 200 non-profit partners across New York. Highmark Blue Cross Blue Shield is an independent licensee of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield companies. For more information, visit www.highmark.com.
About Highmark Blue Shield of Northeastern New York
Highmark Western and Northeastern New York Inc., doing business as Highmark Blue Shield, has roots in the Capital Region dating back to 1946. Today, it is an affiliate of Highmark Inc. and other Highmark health plans, which collectively comprise, the third largest overall Blue Cross Blue Shield-affiliated organization in the country with nearly 8 million members Pennsylvania, Delaware, New York, West Virginia, Missouri and Kansas. The company insures over 100k members and employs nearly 130 team members in the Capital Region. It is one of the region's strongest corporate citizens, investing over $8 million into 200 non-profit partners across New York. The company generates over $1 billion in economic impact in New York. Highmark Blue Shield is an independent licensee of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield companies. For more information, visit www.highmark.com
Amber Hartmann
Highmark Western and Northeastern New York
716-887-8962
Amber.Hartmann@highmarkhealth.org
***
Original text here: https://www.highmark.com/newsroom/press-releases/highmark-announces-2027-affordable-care-act-products-in-new-york
Highmark Announces 2027 Affordable Care Act Products in Delaware
PITTSBURGH, Pennsylvania, Nov. 1 [Category: BizInsurance] -- Highmark, a health insurance company, issued the following news release:
* * *
Highmark Announces 2027 Affordable Care Act Products in Delaware
*
Wilmington, Del. (November 1, 2026) -- Highmark Blue Cross Blue Shield Delaware announced its Affordable Care Act (ACA) health insurance products for 2027, offering individuals and families high-quality and convenient coverage options to fit their lives and health goals.
"For Americans who don't receive insurance through work or another government program, the ACA marketplace protects and
... Show Full Article
PITTSBURGH, Pennsylvania, Nov. 1 [Category: BizInsurance] -- Highmark, a health insurance company, issued the following news release:
* * *
Highmark Announces 2027 Affordable Care Act Products in Delaware
*
Wilmington, Del. (November 1, 2026) -- Highmark Blue Cross Blue Shield Delaware announced its Affordable Care Act (ACA) health insurance products for 2027, offering individuals and families high-quality and convenient coverage options to fit their lives and health goals.
"For Americans who don't receive insurance through work or another government program, the ACA marketplace protects andconnects them to high-quality care," says Mike Pelino, senior director of market strategy and analytics for Highmark. "We encourage consumers to contact our enrollment experts and find the plan that's right for them. Even if you have been assigned to a different carrier, it's important to shop around and know your options."
Roughly 75% of Highmark's ACA Marketplace members in Delaware qualify for tax credits that make their coverage more affordable, and 4 out of 5 can find a plan for $21 or less per month after tax credits in 2027.
"While some national, for-profit insurers enter and exit the ACA marketplace, Highmark has been trusted partner for ACA consumers since the program started more than a decade ago," says Ellen Galardy, president of Federal Business at Highmark. "ACA plans cover all ten essential health benefits, including doctor visits and maternity care, and provide access to important preventive care at no cost to the member. All bronze and catastrophic Individual ACA plans are eligible to be paired with a Health Savings Account, allowing members to use tax-advantaged funds to pay for their care. And, in 2027, we are offering a new bronze plan with a $0 deductible, including prescription medications. It's a great option for cost-conscious consumers looking for first-dollar coverage."
2027 Individual and Family plans
Highmark will offer my Blue Access Select PPO plans across Delaware for 2027. These plans provide individuals and families with access to Highmark's broadest network of doctors and hospitals in the state.
Plus, no plans require referrals to see a specialist and include in-network coverage for services received from 97 percent of hospitals and over 2 million providers nationwide through the BlueCard(r) program, including facilities in Pennsylvania and Maryland.
While the open enrollment period runs through January 15, consumers must enroll by December 15 for coverage that starts on January 1. For more information on Highmark's 2027 ACA health insurance products, visit Highmark.com or call 877-959-2563.
About Highmark Blue Cross Blue Shield Delaware
Highmark BCBSD Inc., doing business as Highmark Blue Cross Blue Shield, serves approximately 475,000 members through the company's health care benefits business. It is an influential company in the market generating an economic impact of $360.2 million and supporting more than 3,600 direct and indirect jobs across the state. Highmark Blue Cross Blue Shield has been named a Top Workplace in Delaware and a Top Workplace USA. Highmark Blue Cross Blue Shield is an independent licensee of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield companies. For more information, visit www.highmarkcom.
Denee Crumrine
Highmark Health
302-421-2448
Denee.crumrine@highmarkhealth.org
***
Original text here: https://www.highmark.com/newsroom/press-releases/highmark-announces-2027-affordable-care-act-products-in-delaware
